These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3038298)

  • 41. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
    Hallager S; Ladelund S; Kjaer M; Madsen LG; Belard E; Laursen AL; Gerstoft J; Røge BT; Grønbaek KE; Krarup HB; Christensen PB; Weis N
    J Viral Hepat; 2018 Jan; 25(1):47-55. PubMed ID: 28750141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical characteristics, treatment patterns and survival outcome of hepatocellular carcinoma patients aged 70 years or older: a single-center retrospective study from China.
    Fan C; Jin G; Sun C; Ma D; Chen C; Qiao P; Wu D
    Aging Clin Exp Res; 2014 Apr; 26(2):123-30. PubMed ID: 24129805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Case-control studies of hepatocellular carcinoma and liver cirrhosis in relation to life style and other risk factors].
    Tanaka K; Hirohata T; Takeshita S
    Gan No Rinsho; 1990 Feb; Spec No():305-12. PubMed ID: 2156092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma.
    Zhou XD; DeTolla L; Custer RP; London WT
    Cancer; 1987 Apr; 59(8):1430-7. PubMed ID: 3028601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The natural history of chronic hepatitis B: a retrospective study.
    Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
    Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.
    Van Roey G; Fevery J; Van Steenbergen W
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):61-6. PubMed ID: 10656212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
    Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls.
    Wang LY; Chen CJ; Zhang YJ; Tsai WY; Lee PH; Feitelson MA; Lee CS; Santella RM
    Am J Epidemiol; 1998 Feb; 147(3):315-23. PubMed ID: 9482507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.
    Zaman SN; Melia WM; Johnson RD; Portmann BC; Johnson PJ; Williams R
    Lancet; 1985 Jun; 1(8442):1357-60. PubMed ID: 2861313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies.
    Do AL; Wong CR; Nguyen LH; Nguyen VG; Trinh H; Nguyen MH
    J Clin Gastroenterol; 2014 Aug; 48(7):644-9. PubMed ID: 24201999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing incidence of hepatocellular carcinoma in Japan.
    Okuda K; Fujimoto I; Hanai A; Urano Y
    Cancer Res; 1987 Sep; 47(18):4967-72. PubMed ID: 3040235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia.
    Umoh NJ; Lesi OA; Mendy M; Bah E; Akano A; Whittle H; Hainaut P; Kirk GD
    Liver Int; 2011 Feb; 31(2):215-21. PubMed ID: 21143369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Higaki I; Takemura S; Yamamoto T; Nishiguchi S; Kinoshita H
    Dig Surg; 2001; 18(1):26-33. PubMed ID: 11244256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Epidemiology of hepatocellular carcinoma].
    Ricca Rosellini S; Miglio F
    Minerva Gastroenterol Dietol; 1991; 37(2):73-84. PubMed ID: 1660311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.